University of Maryland
Linda Wastila, BSPharm, MSPH, PhD, is Professor and Parke-Davis Chair of Geriatric Pharmacotherapy in the University of Maryland Baltimore School of Pharmacy. For almost thirty years, Dr. Wastila has conducted health services policy research with a focus on pharmaceutical health policy and drug safety. Trained in pharmacy and public health, her expertise in analyzing large databases, including Medicare, Medicaid, and proprietary claims data, has landed her grants and contracts funded by NIDA, NIA, SAMHSA, CMS, FDA, AHRQ, state governments, and foundations. With more than 150 peer-reviewed publications to her credit, she has demonstrated experience in assessing the impacts of public health policies on resources utilization and costs, drug therapy appropriateness, medication adherence, and outcomes, including hospitalization/rehospitalization, morbidity, and mortality. Dr. Wastila has served as technical expert and advisory committee member for FDA, CMS, and CDC.
Dr. Wastila's Capitol Speech Nov 2, 2021: